
Joseph Patrick Erinjeri MD PhD
Member, Memorial Sloan Kettering Cancer Center Professor of Radiology, Weill Cornell Medical College
Join to View Full Profile
530 East 74th StreetNew York, NY 10021
Dr. Erinjeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 2007 - 2008
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2007 - 2008
- Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 2003 - 2007
- Virginia Mason Franciscan HealthInternship, Internal Medicine, 2002 - 2003
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
- NY State Medical License 2007 - 2026
- NJ State Medical License 2017 - 2025
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Vascular & Interventional Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsEvaluation of the Ki-67 labeling index on immediate pre-ablation biopsies as a predictive biomarker of local recurrence of colorectal cancer liver metastases.Vlasios S Sotirchos, Efsevia Vakiani, Carlie Sigel, Rami Imam, Henry S Kunin
Cytotechnology. 2025-02-01 - TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.Ken Zhao, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli
Current Oncology. 2025-01-18 - 8 citationsDurvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo...Bruno Sangro, Masatoshi Kudo, Joseph P Erinjeri, Shukui Qin, Zhenggang Ren
Lancet. 2025-01-18
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
- Schedule at A GlanceJune 8th, 2015
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: